In addition, UCSB has been developing relations with
major biotechnology companies in order to more rapidly share and apply its findings and has collaborated with five other research institutions to form Southern California Stem Cell Scientific Collaboration to share experiences and ideas.
The meeting was attended by over 270 registered participants from over 30 countries, e.g. Brazil, China, South Africa, United Arab Emirates, Russia, Singapore, and several European countries and supported by
all major biotechnology companies, such as Agilent, Illumina, Roche Diagnostics, Life Technologies, etc..
The other panelists were a scientist / manager from
a major biotechnology company and a physicist - turned - businessman from a Silicon Valley high - tech company.
Project Manager, Cell Culture Development (Ph.D.)
Major biotechnology Company; Location: San Francisco, California, area Compensation: $ 85K + bonus + stock options
Not exact matches
Political risk consulting
company Eurasia Group says that other measures the Trump administration may soon roll out could include blocking Chinese cloud services
companies from establishing data centres in the U.S.; a renewed emphasis on restricting sales of Chinese telecommunications equipment to
major U.S. operators; and prohibiting Chinese acquisitions of U.S. firms in sectors such as artificial intelligence, automation, robotics, semiconductors and
biotechnology.
The Index reflects
companies across
major industry groups including computer hardware and software, telecommunications, retail / wholesale trade and
biotechnology, but does not contain securities of financial
companies.
Many
major pharmaceutical
companies have stopped researching and developing new antibiotics altogether, shifting more of that responsibility to smaller, nimbler
biotechnology startups.
Confidence in
biotechnology companies was jolted last week by the news that a
major clinical trial of a drug to combat severe blood poisoning had been halted.
Not for nothing are
major agrochemicals and
biotechnology companies investing heavily in developing such transgenic crops.
We established formal partnerships with
major pharmaceutical and
biotechnology companies to develop compounds or identify targets that enhance interneuron function or restore brain rhythms in models of AD and epilepsy.
PsychoGenics works with pharmaceutical and
biotechnology companies, academic institutions and not - for - profit research foundations to address such
major neurological disorders as: ALS, Huntington's Disease, anxiety, cognitive impairment, depression, psychosis / schizophrenia and SMA.
We recently represented a consortium of four
major Chinese PE funds in its acquisition of Ambrx, Inc. (a
biotechnology company based in San Diego).